A Phase 1b, Randomized, Single-Center Trial of Topical Cerdulatinib (DMVT-502) in Patients with Mild-to-Moderate Atopic Dermatitis - Concepedia

Concepedia

Publication | Closed Access

A Phase 1b, Randomized, Single-Center Trial of Topical Cerdulatinib (DMVT-502) in Patients with Mild-to-Moderate Atopic Dermatitis

27

Citations

3

References

2021

Year

Stephen C. Piscitelli, Ana B. Pavel, Kimberly McHale, John E Jett, Jon Collins, Dawn Gillmor, Glenn Tabolt, Randall Li, Teresa Song, N. Zhang,

Journal of Investigative Dermatology

Phase 1BTopical CerdulatinibSingle-center TrialAtopic DermatitisSkin AllergyClinical DermatologyDermatologyMedicine

References

	Year	Citations

Page 1

Page 1